Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Salzmann: Cost-effectiveness of extending screening mammography guidelines to include women.... (0.07 sec) 

Cost-effectiveness of extending screening mammography guidelines to include women 40 to …

- annals.org
P Salzmann, K Kerlikowske, K Phillips - Annals of Internal Medicine, 1997 - Am Coll Physicians
Background: Screening mammography is recommended for women 50 to 69 years of age
because of its proven efficacy and reasonable cost-effectiveness. Extending
screening recommendations to include women 40 to 49 years of age remains ...
Cited by 206 - Related articles - BL Direct - All 5 versions

The cost-effectiveness of mammographic screening strategies

- epi-ucsf.org [PDF] 
KK Lindfors, J Rosenquist - Obstetrical & Gynecological Survey, 1996 - journals.lww.com
The authors compared mammographic screening to observation without screening
using a computer simulation model developed for this purpose. Cost-effectiveness
was expressed as marginal cost per year of life saved (MCYLS), which is ...
Cited by 109 - Related articles - BL Direct - All 11 versions

Continuing screening mammography in women aged 70 to 79 years: impact on life …


K Kerlikowske, P Salzmann, KA Phillips, JA … - Jama, 1999 - Am Med Assoc
Context Mammography is recommended and is cost-effective for women aged 50 to 69
years, but the value of continuing screening mammography after age 69 years is
not known. In particular, older women with low bone mineral density (BMD) ...
Cited by 145 - Related articles - All 3 versions

Screening mammography beginning at age 40 years


CJ Rosenquist, KK Lindfors - CA A Cancer Journal for Clinicians - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 40 - Related articles - BL Direct - All 3 versions

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized …


RE Hendrick, RA Smith, JH Rutledge 3rd, CR … - Journal of the National Cancer Institute. Monographs, 1997 - ncbi.nlm.nih.gov
Eight randomized controlled trials (RCTs) of screening mammography have been
conducted involving women aged 40-49 at entry. Current data are now available
from these trials at 10.5 to 18 years of follow-up (average follow-up time: ...
Cited by 239 - Related articles

Likelihood ratios for modern screening mammography. Risk of breast cancer based on age …


K Kerlikowske, D Grady, J Barclay, EA Sickles, … - Jama, 1996 - Am Med Assoc
OBJECTIVE--To determine the sensitivity, specificity, and likelihood ratios
(LRs) for modern screening mammography by decade of age and mammographic
interpretation. DESIGN--Cross-sectional. SETTING--Nine counties in northern ...
Cited by 139 - Related articles - All 3 versions

Ten-year risk of false positive screening mammograms and clinical breast examinations


JG Elmore, MB Barton, VM Moceri, S Polk, PJ … - The New England Journal of Medicine, 1998 - nejm.highwire.org
Results A total of 9762 screening mammograms and 10,905 screening clinical
breast examinations were performed, for a median of 4 mammograms and 5 clinical
breast examinations per woman over the 10-year period. Of the women who ...
Cited by 606 - Related articles - BL Direct - All 6 versions

Stratification of palpable and nonpalpable breast cancer by method of detection and age


PW Perdue, C Galbo, BC Ghosh - Annals of Surgical Oncology, 1995 - Springer
Background: Methods used to diagnose breast cancer in women under the age of 50
years are somewhat controversial. To determine the relationship between type and
stage of breast cancer, clinical presentation, and age, we reviewed breast ...
Cited by 5 - Related articles - All 3 versions

COST"" OUTLINE


LL Subak - Evidence-based medicine: a framework for clinical …, 1998 - books.google.com
84/CHAPTER 4 You represent the Gynecology Department on a committee your health
maintenance or- ganization (HMO) has assembled to consider revision of your
policy on screening mam- mography. Currently, you offer screening ...
Related articles

[CITATION] COST-EFFECTIVENESS ANALYSIS


LL Subak - Evidence-Based Medicine: A Framework for Clinical …, 1998 - McGraw-Hill Medical
Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google